Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 12Hodgkin Disease 11Urinary Bladder Neoplasms 7Urethral Neoplasms 3Melanoma 2Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1HIV Infections 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Astrocytoma 1

Interventions

Temozolomide 14Radiotherapy 8Vincristine 5Procarbazine 3Lomustine 3lonafarnib 2imetelstat 2Topotecan 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Irinotecan 2Carboplatin 2veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1palbociclib 1emvododstat 1azurin (50-77) 1Vinblastine 1Semaxinib 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1GRN163L peptide 1Dexamethasone 1DNA Methylation 1Chemotherapy, Adjuvant 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Oligodendroglioma × Vinblastine × Clear all
NCT00352495 2014-02-13

Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

Children's Oncology Group

Phase 1 Completed
26 enrolled
CNS

Astrocytoma, Neurofibromatosis 1, Oligodendroglioma, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡